Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Zhenghua Pharmaceutical is a Chinese pharmaceutical manufacturing company based in Dunhua, Jilin Province. Established in 2003, the company specializes in the production of Traditional Chinese Medicines (TCM) and generic chemical drugs, with a strong focus on pediatric oral liquids and cardiovascular treatments. Its flagship products include Huangzhihua Oral Liquid for pediatric respiratory infections and Shen Bian Bu Shen Mixture for kidney health. The company maintains GMP-certified manufacturing capabilities for various formulations, including injections, oral liquids, and capsules. Jilin Zhenghua primarily serves the domestic Chinese healthcare market through hospital and retail pharmacy channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Zhenghua Pharmaceutical.